Multiomics Services Market Report 2026

Multiomics Services Market Overview

• Multiomics Services market size has reached to $1.42 billion in 2025 • Expected to grow to $3.56 billion in 2030 at a compound annual growth rate (CAGR) of 20.1% • Growth Driver: Increasing Adoption Of Personalized Medicine Fueling The Growth Of The Market Due To People Preferring Health Technologies • Market Trend: Genomics Advances Multiomics Services With 3D Genome Mapping Technology To Boost Drug Discovery • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Multiomics Services Market?

Multiomics services refer to a comprehensive approach in biological research that involves the integration of various omics data types such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics. This approach allows for the combined analysis of different biological layers to gain a complete understanding of complex biological systems. The main types of multiomics services include single-cell multiomics and bulk multiomics. Single-cell multiomics refers to the integration and simultaneous analysis of multiple types of molecular data, such as genomics, transcriptomics, proteomics, and epigenomics, at the resolution of individual cells. It is used for various applications, including biomarker discovery, drug discovery and development, synthetic biology, and others, and caters to several end users, such as academic and research institutes, pharmaceutical and biotechnology companies, and others.

What Is The Multiomics Services Market Growth Forecast?

The multiomics services market size is expected to see exponential growth in the next few years. It will grow to $3.56 billion in 2030 at a compound annual growth rate (CAGR) of 20.1%. The growth in the forecast period can be attributed to increasing adoption of precision medicine approaches, rising pharmaceutical investment in systems biology, expansion of multiomics applications in drug discovery, growing use of ai-based biological data interpretation, increasing demand for personalized therapeutic development. Major trends in the forecast period include increasing adoption of integrated multiomics analysis platforms, rising demand for single-cell multiomics services, growing use of data-driven biological insights, expansion of cloud-based omics data integration, enhanced focus on translational research applications.

What Is The Driver Of The Multiomics Services Market?

The increasing adoption of personalized medicine is expected to propel the growth of the multiomics services market going forward. Personalized medicine refers to a medical model that uses information about a person’s genes and lifestyle environment to tailor treatments and healthcare to their specific needs. The increasing adoption of personalized medicine is due to people preferring health technologies that offer real-time monitoring and treatment plans customized to their unique biology. Multiomics services support advancing personalized medicine by integrating diverse biological data such as genomics, transcriptomics, proteomics, and metabolomics to provide a comprehensive understanding of an individual's health profile, thereby enabling tailored diagnosis, treatment, and disease prevention strategies. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase from the 12 approved in 2022. Therefore, the increasing adoption of personalized medicine is driving the growth of the multiomics services industry.

Key Players In The Global Multiomics Services Market

Major companies operating in the multiomics services market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, QIAGEN NV, Azenta Inc., BGI Group, 10x Genomics Inc., BioLegend Inc., Oxford Nanopore Technologies Plc, NanoString Technologies Inc., Pacific Biosciences Inc., Metware Biotechnology Inc., Source BioScience Limited, CD Genomics Inc., Psomagen Inc., Creative Proteomics, Sapient Bioanalytics LLC, Dalton Bioanalytics Inc., Clinical Microbiomics A/S.

Global Multiomics Services Market Trends and Insights

Major companies operating in the multiomics services market are focusing on developing innovative approaches, such as 3D genome mapping, to enhance the understanding of gene regulation, disease mechanisms, and personalized treatment strategies. 3D genome mapping refers to the process of determining the three-dimensional spatial organization of the genome within the nucleus of a cell. For instance, in January 2025, Enhanc3D Genomics, a UK-based biotechnology company, launched a suite of 3D multi-omics solutions to accelerate and improve the precision of drug discovery. It offers unique features such as integration of genome-wide regulatory interaction data with multi-omics profiles in a single assay, enabling comprehensive insights into gene regulation. Its proprietary Promoter Capture Hi-C technology allows precise mapping of long-range interactions between regulatory elements and target genes, including those in non-coding regions. The platform’s modular design featuring GenLinkConnect, GenLinkResponse, and GenLinkProfile supports SNP-to-gene linkage, drug response analysis, and cell-specific regulatory profiling, respectively. Additionally, the GenLinkHub software provides an intuitive interface for 3D visualization, data management, and quality control, enhancing researchers’ ability to interpret complex datasets and accelerate drug discovery.

What Are Latest Mergers And Acquisitions In The Multiomics Services Market?

In June 2025, Bruker Corporation, a US-based scientific instruments and analytical solutions company, acquired Biocrates Life Sciences AG for an undisclosed amount. Through this acquisition, Bruker aims to enhance its multiomics strategy by integrating Biocrates advanced metabolomics and lipidomics technologies with its existing proteomics workflows. Biocrates Life Sciences AG is an Austria-based biotechnology company that specializes in multiomics services.

What Defines the Multiomics Services Market?

The multiomics services market includes revenues earned by entities by providing services such as genomics analysis, transcriptomics profiling, proteomics services, metabolomics analysis, and epigenomics studies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Multiomics Services Market Report 2026?

The multiomics services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the multiomics services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.